Core Viewpoint - iFlytek Medical Technology (02506.HK) is leveraging its advanced technological capabilities, extensive customer base, and brand recognition to enhance operational efficiency and capture new profit opportunities through a collaborative commercialization strategy [1] Financial Performance - For the six months ending June 30, 2025, the company reported revenue of RMB 299 million, an increase of 30.3% compared to RMB 229.2 million in the same period last year [1] - The gross profit for the same period was RMB 153.9 million, reflecting a 27.0% increase from the previous year's gross profit [1] - The gross margin stood at 51.5%, slightly down by 1.3 percentage points from the same period last year, primarily due to a decrease in the gross margin of grassroots solution business in the first half of 2025 [1] Future Outlook - The company anticipates rapid revenue growth as its product offerings become more diverse and mature, while maintaining a relatively stable overall gross margin level [1]
讯飞医疗科技(02506.HK)：上半年录得收入2.99亿元 同比增加30.3%